Coronary artery disease
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1) Patient with a de novo lesion in which stent will be implanted 2) Patient who has a side branch with visually confirmed luminal diameter of 2 mm or more 3) Age 20 years or older
Exclusion criteria
Exclusion criteria: 1) Patient who has a stent restenosis lesion in which stent will be implanted 2) Patient with cardiogenic shock 3) Patient with a STEMI and CTO lesion 4) Patient who is considered PCI not applicable 5) Patient whom physician in charge of the study determined not applicable
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Bifurcation area restenosis within a year after PCI in the Optimal group with side branch dilatation, Suboptimal group and the group with no side branch dilatation. (50% or more stenosis progression from immediately after the clinical trial due to nature of coronary angiography) | — |
Secondary
| Measure | Time frame |
|---|---|
| Rate of major adverse cardiovascular events within 3 years after PCI. Cardiac death, non-cardiac death, myocardial infarction, stent thrombosis, target lesion revascularization (TLR), target vessel revascularization (TVR), and renal dysfunction. <Exploratory parameter> An exploratory study on bifurcation stenting using 3D OCT imaging guide *Jailed strut pattern, success rate of optimal cell re-crossing, PCI procedure time, contrast usage, and fluoroscopy time. | — |
Countries
Japan
Contacts
Osaka Saiseikai Nakatsu Hospital Cardiology